Literature DB >> 10024356

Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.

E V Kuzhikandathil1, G S Oxford.   

Abstract

The D3 dopamine receptor is postulated to play an important role in the regulation of neurotransmitter secretion at both pre- and postsynaptic terminals. However, this hypothesis and the underlying mechanisms remain untested because of the lack of D3-selective ligands, paucity of appropriate model secretory systems, and the weak and inconsistent coupling of D3 receptors to classical signal transduction pathways. The absence of ligands that selectively discriminate between D3 and D2 receptors in vivo precludes the study of D3 receptor function in the brain and necessitates the use of heterologous expression systems. In this report we demonstrate that activation of the human D3 dopamine receptor expressed in the AtT-20 neuroendocrine cell line causes robust inhibition of P/Q-type calcium channels via pertussis toxin-sensitive G-proteins. In addition, using the vesicle trafficking dye FM1-43, we show that D3 receptor activation significantly inhibits spontaneous secretory activity in these cells. Our results not only support the hypothesis that the D3 receptor can regulate secretory activity but also provide insight into the underlying signaling mechanisms. We propose a functional model in which the D3 receptor tightly regulates neurotransmitter release at a synapse by only allowing the propagation of spikes above a certain frequency or burst-duration threshold.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024356      PMCID: PMC6782181     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

Review 1.  Imaging exocytosis and endocytosis.

Authors:  W J Betz; F Mao; C B Smith
Journal:  Curr Opin Neurobiol       Date:  1996-06       Impact factor: 6.627

2.  Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

Authors:  T Momiyama; T Amano; N Todo; M Sasa
Journal:  Eur J Pharmacol       Date:  1996-08-22       Impact factor: 4.432

3.  Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus.

Authors:  J I Luebke; K Dunlap; T J Turner
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

Review 4.  Dopamine D3 receptor: basic and clinical aspects.

Authors:  J C Schwartz; D Levesque; M P Martres; P Sokoloff
Journal:  Clin Neuropharmacol       Date:  1993-08       Impact factor: 1.592

5.  Pharmacological identification of two types of presynaptic voltage-dependent calcium channels at CA3-CA1 synapses of the hippocampus.

Authors:  L G Wu; P Saggau
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

6.  Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.

Authors:  B Bowery; L A Rothwell; G R Seabrook
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells.

Authors:  A Winkler; G Papsdorf; J Odarjuk; W E Siems; J Fickel; M F Melzig
Journal:  Eur J Pharmacol       Date:  1995-09-15       Impact factor: 4.432

8.  Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release.

Authors:  T J Turner; M E Adams; K Dunlap
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.

Authors:  T Reisine; H L Wang; S Guild
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype.

Authors:  Y C Patel; R Panetta; E Escher; M Greenwood; C B Srikant
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

View more
  14 in total

1.  Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model.

Authors:  Ying Li; Eldo V Kuzhikandathil
Journal:  Brain Struct Funct       Date:  2012-01-29       Impact factor: 3.270

Review 2.  Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

Authors:  Amy E Moritz; R Benjamin Free; David R Sibley
Journal:  Cell Signal       Date:  2017-07-14       Impact factor: 4.315

3.  Interaction of D₃ preferring agonist (-)-N⁶-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D₂L, D₂S, and D₃ receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels.

Authors:  Eldo V Kuzhikandathil; Samantha Cote; Soumava Santra; Aloke K Dutta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-20       Impact factor: 3.000

4.  Amphetamine blocks long-term synaptic depression in the ventral tegmental area.

Authors:  S Jones; J L Kornblum; J A Kauer
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 5.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

6.  Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.

Authors:  Hui Zhang; David Sulzer
Journal:  Basal Ganglia       Date:  2012-03-01

Review 7.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

8.  An amino acid residue in the second extracellular loop determines the agonist-dependent tolerance property of the human D3 dopamine receptor.

Authors:  Sara Gil-Mast; Sandhya Kortagere; Kokila Kota; Eldo V Kuzhikandathil
Journal:  ACS Chem Neurosci       Date:  2013-03-21       Impact factor: 4.418

9.  Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.

Authors:  Davide Cervia; Caroline Nunn; Dominique Fehlmann; Daniel Langenegger; Edi Schuepbach; Daniel Hoyer
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 10.  Dopamine receptor signaling and current and future antipsychotic drugs.

Authors:  Kevin N Boyd; Richard B Mailman
Journal:  Handb Exp Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.